Panacea Biotec Ltd.

PANACEABIO

Market Cap
₹836 Cr.
P/E
0.00

Panacea Biotec Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics
Other Income
Other Income component is making ratios of the company look optically better
Capex vs ROCE
ROCE of the company has decreased even without significant capex
Depreciation Effect
Company is depreciating a lower percentage of assets. This is contributing to an increase in Net Profit
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Company is converting accounting profit to cash
Contingent Liabilities
Company has significant contigent liabilities which can be risky
Retail Holding
Retail has been buying the stock which is usually a sign of exuberance
Share price
Share price has decreased over last 10 years more due to earnings
ROE
Asset Turnover is responsible for ROE increase over last 10 years
Working Capital
Company has significant working capital which is dragging its ROCE and ROE
Debt
Company might have issues servicing its debt
Current vs Historic Valuation
Unable to calculate due to limited data
Promoter Holding
Promoter has not sold any shares in the last 90 days
ROE
Latest
-3.94%
3yr Average
61.22%
5yr Average
19.34%
Net Profit Margin
Latest
-7.23%
3yr Average
44.07%
5yr Average
20.95%
ROCE
Latest
-9.07%
3yr Average
-2.75%
5yr Average
-10.17%
Debt to Equity
Latest
0.02
3yr Average
-1.17
5yr Average
0.41
Market Share
0.01% (as of Jul 22)
Anti - Diabetes - Market Share
0.01% (as of Jul 22)
Anti-Infectives - Market Share
3.44% (as of Nov 21)
Antineo Plastic - Market Share
0.04% (as of Nov 21)
Blood Related - Market Share
0.01% (as of Jul 18)
Cardiovascular - Market Share
0.02% (as of Nov 21)
Endocrinology - Market Share
0% (as of Jul 22)
Gastro-Intestinal - Market Share
0.03% (as of Nov 21)
Gynecology - Market Share
0.01% (as of Nov 21)
Neurological - Market Share
0.25% (as of Nov 21)
Pain - Market Share
0.04% (as of Jul 22)
Pharmaceutical Sector - Market Share
0.02% (as of Nov 21)
Respiratory - Market Share
4.02% (as of Jul 22)
Vaccines - Market Share
0% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Wise Break-Up - Domestic

Latest
|
locked
Historic

Location Wise Break-Up -Vaccines

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -Formulations

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Break-Up -India

Latest
|
locked
Historic

Operating Profit Break-Up

locked
Source
|
Latest
|
locked
Historic

Capex

locked
Source
|
Latest
|
locked
Historic

Brand Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline